<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on September 20, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/ct2/show/NCT04422574</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL20_0343</org_study_id>
    <nct_id>NCT04422574</nct_id>
  </id_info>
  <brief_title>COVID 19 Serology in Pulmonologists</brief_title>
  <acronym>Pneumoserocov</acronym>
  <official_title>COVID 19 Serology in Pulmonologists : Pneumo Sero Cov</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Respiratory physicians are highly exposed workers to Covid-19 as they perform spirometry,&#xD;
      endoscopy, and manage Covid-19 in first line for most of them. Moreover, none reported to&#xD;
      have apply increased levels of protection for performing these acts in the most active period&#xD;
      of viral circulation, until the lockdown. Whether they were most frequently immunized against&#xD;
      SARS-CoV-2 at the end of the first wave than the general population is of utmost importance&#xD;
      individually but also worldwide&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 1, 2020</start_date>
  <completion_date type="Actual">May 30, 2020</completion_date>
  <primary_completion_date type="Actual">May 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Ecologic or Community</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>covid 19 serology</measure>
    <time_frame>1 day</time_frame>
    <description>covid 19 serology with cross sectional</description>
  </primary_outcome>
  <primary_outcome>
    <measure>risk factors for positive serology testing</measure>
    <time_frame>1 day</time_frame>
    <description>risk factors for positive serology testing with cross sectional</description>
  </primary_outcome>
  <enrollment type="Actual">97</enrollment>
  <condition>Covid 19</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Pulmonologists of Languedoc Roussillon&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Pulmonologists of Languedoc Roussillon&#xD;
&#xD;
          -  Actively working&#xD;
&#xD;
          -  Registered&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  refusal to participate&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arnaud Bourdin, MD PhD</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital, Montpellier</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Uh Montpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 8, 2020</study_first_submitted>
  <study_first_submitted_qc>June 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 9, 2020</study_first_posted>
  <last_update_submitted>June 8, 2020</last_update_submitted>
  <last_update_submitted_qc>June 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Covid 19</keyword>
  <keyword>serology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>NC</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>


download date: ClinicalTrials.gov processed this data on September 20, 2023
link text: Link to the current ClinicalTrials.gov record.
url: https://clinicaltrials.gov/ct2/show/NCT04422574
org study id: RECHMPL20_0343
nct id: NCT04422574
lead sponsor: 
has dmc: No
is fda regulated drug: No
is fda regulated device: No
Respiratory physicians are highly exposed workers to Covid-19 as they perform spirometry,
      endoscopy, and manage Covid-19 in first line for most of them. Moreover, none reported to
      have apply increased levels of protection for performing these acts in the most active period
      of viral circulation, until the lockdown. Whether they were most frequently immunized against
      SARS-CoV-2 at the end of the first wave than the general population is of utmost importance
      individually but also worldwide
observational model: Ecologic or Community
time perspective: Cross-Sectional
measure: covid 19 serology
time frame: 1 day
description: covid 19 serology with cross sectional
measure: risk factors for positive serology testing
time frame: 1 day
description: risk factors for positive serology testing with cross sectional
study pop: 
sampling method: Non-Probability Sample
criteria: 
gender: All
minimum age: 18 Years
maximum age: N/A
healthy volunteers: No
last name: Arnaud Bourdin, MD PhD
role: Study Director
affiliation: University Hospital, Montpellier
facility: 
country: France
responsible party type: Sponsor
mesh term: COVID-19
sharing ipd: Undecided
ipd description: NC